Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acetylation is indispensable for p53 antiviral activity.
Muñoz-Fontela C, González D, Marcos-Villar L, Campagna M, Gallego P, González-Santamaría J, Herranz D, Gu W, Serrano M, Aaronson SA, Rivas C. Muñoz-Fontela C, et al. Cell Cycle. 2011 Nov 1;10(21):3701-5. doi: 10.4161/cc.10.21.17899. Epub 2011 Nov 1. Cell Cycle. 2011. PMID: 22033337 Free PMC article.
Dual Role of p53 in Innate Antiviral Immunity.
Rivas C, Aaronson SA, Munoz-Fontela C. Rivas C, et al. Viruses. 2010 Jan;2(1):298-313. doi: 10.3390/v2010298. Epub 2010 Jan 22. Viruses. 2010. PMID: 21994612 Free PMC article.
SUMOylation of p53 mediates interferon activities.
Marcos-Villar L, Pérez-Girón JV, Vilas JM, Soto A, de la Cruz-Hererra CF, Lang V, Collado M, Vidal A, Rodríguez MS, Muñoz-Fontela C, Rivas C. Marcos-Villar L, et al. Cell Cycle. 2013 Sep 1;12(17):2809-16. doi: 10.4161/cc.25868. Epub 2013 Aug 5. Cell Cycle. 2013. PMID: 23966171 Free PMC article.
Transcriptional role of p53 in interferon-mediated antiviral immunity.
Muñoz-Fontela C, Macip S, Martínez-Sobrido L, Brown L, Ashour J, García-Sastre A, Lee SW, Aaronson SA. Muñoz-Fontela C, et al. J Exp Med. 2008 Aug 4;205(8):1929-38. doi: 10.1084/jem.20080383. Epub 2008 Jul 28. J Exp Med. 2008. PMID: 18663127 Free PMC article.
Antiviral action of the tumor suppressor ARF.
García MA, Collado M, Muñoz-Fontela C, Matheu A, Marcos-Villar L, Arroyo J, Esteban M, Serrano M, Rivas C. García MA, et al. EMBO J. 2006 Sep 20;25(18):4284-92. doi: 10.1038/sj.emboj.7601302. Epub 2006 Sep 7. EMBO J. 2006. PMID: 16957780 Free PMC article.
Control of virus infection by tumour suppressors.
Muñoz-Fontela C, García MA, Collado M, Marcos-Villar L, Gallego P, Esteban M, Rivas C. Muñoz-Fontela C, et al. Carcinogenesis. 2007 Jun;28(6):1140-4. doi: 10.1093/carcin/bgm048. Epub 2007 Mar 7. Carcinogenesis. 2007. PMID: 17347139 Review.
Resistance to viral infection of super p53 mice.
Munoz-Fontela C, Garcia MA, Garcia-Cao I, Collado M, Arroyo J, Esteban M, Serrano M, Rivas C. Munoz-Fontela C, et al. Oncogene. 2005 Apr 21;24(18):3059-62. doi: 10.1038/sj.onc.1208477. Oncogene. 2005. PMID: 17726827
KSHV latent protein LANA2 inhibits sumo2 modification of p53.
Laura MV, de la Cruz-Herrera CF, Ferreirós A, Baz-Martínez M, Lang V, Vidal A, Muñoz-Fontela C, Rodríguez MS, Collado M, Rivas C. Laura MV, et al. Cell Cycle. 2015;14(2):277-82. doi: 10.4161/15384101.2014.980657. Cell Cycle. 2015. PMID: 25607652 Free PMC article.
86 results